During observation, at least 57% (n = 227) of our patients exhibited other abnormalities e.g., DAT positivity, antibody deficiency, malignancies, or other diseases and abnormalities, Based on our experiences [53], the common classification into a primary and a secondary disease is not certain and variable in many cases. The gene discussed is SLC6A3; the disease is agammaglobulinemia.